175 related articles for article (PubMed ID: 9651732)
21. Influence of nifedipine coat-core and amlodipine on systemic arterial stiffness modulated by sympathetic and parasympathetic activity in hypertensive patients.
Fukuda M; Masuda T; Ogura MN; Moriya T; Tanaka K; Yamamoto K; Ishii A; Yonezawa R; Noda C; Izumi T
Hypertens Res; 2009 May; 32(5):392-8. PubMed ID: 19373239
[TBL] [Abstract][Full Text] [Related]
22. Effects of antihypertensive therapies on the sympathetic nervous system.
de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
[TBL] [Abstract][Full Text] [Related]
23. Heart rate as a sympathetic marker during acute adrenergic challenge.
Grassi G; Seravalle G; Bolla G; Quarti-Trevano F; Dell'Oro R; Arenare F; Mancia G
J Hypertens; 2008 Jan; 26(1):70-5. PubMed ID: 18090542
[TBL] [Abstract][Full Text] [Related]
24. Hypotensive action of calcium antagonists as related to plasma noradrenaline and reactivity to noradrenaline.
Schwietzer G; Distler A; Reeck S; Thiede HM; Philipp T
J Hypertens Suppl; 1983 Dec; 1(2):102-4. PubMed ID: 6400109
[TBL] [Abstract][Full Text] [Related]
25. Sympathetic cardiac influence and arterial blood pressure instability.
Formes KJ; Wray DW; O-Yurvati AH; Weiss MS; Shi X
Auton Neurosci; 2005 Mar; 118(1-2):116-24. PubMed ID: 15795185
[TBL] [Abstract][Full Text] [Related]
26. Fenfluramine lowers plasma norepinephrine in overweight subjects.
Chernow B; Lake CR; Cook D; Coyle J; Hughes P; Coleman MD; Ziegler MG
Int J Clin Pharmacol Res; 1983; 3(4):233-7. PubMed ID: 6678821
[TBL] [Abstract][Full Text] [Related]
27. Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.
Kenyon KW
Ann Pharmacother; 2009 Jul; 43(7):1258-65. PubMed ID: 19584385
[TBL] [Abstract][Full Text] [Related]
28. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
Ruzicka M; Coletta E; Leenen FH
Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368
[TBL] [Abstract][Full Text] [Related]
29. Paradoxical elevation of sympathetic activity during catecholamine infusion in rats.
Johnson MD; Smith PG; Mills E; Schanberg SM
J Pharmacol Exp Ther; 1983 Oct; 227(1):254-9. PubMed ID: 6312020
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
[TBL] [Abstract][Full Text] [Related]
31. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension.
Tanaka T; Tsutamoto T; Sakai H; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2007 Aug; 30(8):691-7. PubMed ID: 17917316
[TBL] [Abstract][Full Text] [Related]
33. Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension.
Binggeli C; Corti R; Sudano I; Luscher TF; Noll G
Hypertension; 2002 Apr; 39(4):892-6. PubMed ID: 11967245
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of action of calcium antagonists in hypertension.
Kiowski W; Bolli P; Erne P; Hulthén UL; Bühler FR
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S23-8. PubMed ID: 2455134
[TBL] [Abstract][Full Text] [Related]
35. [Calcium channel blocker].
Matsuoka H
Nihon Rinsho; 1998 Oct; 56(10):2607-11. PubMed ID: 9796326
[TBL] [Abstract][Full Text] [Related]
36. New approach for measurement of sympathetic nervous abnormality in conscious, spontaneously hypertensive rats.
Tsunoda M; Takezawa K; Santa T; Ina Y; Nagashima K; Ohmori K; Kobayashi S; Imai K
Jpn J Pharmacol; 2000 May; 83(1):39-45. PubMed ID: 10887939
[TBL] [Abstract][Full Text] [Related]
37. Evidence of increased sympathetic vasomotor drive with shorter acting dihydropyridine calcium channel antagonists in human hypertension: a study using spectral analysis of RR interval and systolic arterial pressure variability.
Lucini D; Mela GS; Malliani A; Pagani M
J Cardiovasc Pharmacol; 1997 May; 29(5):676-83. PubMed ID: 9213212
[TBL] [Abstract][Full Text] [Related]
38. Calcium antagonists in hypertension.
Bühler FR; Kiowski W
J Hypertens Suppl; 1987 Aug; 5(3):S3-10. PubMed ID: 3312526
[TBL] [Abstract][Full Text] [Related]
39. [Effect of calcium inhibitors on sympathetic activity].
de Leeuw PW; Blok WL; van Es PN; Tchang PT; Birkenhäger WH
Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():51-4. PubMed ID: 3937506
[TBL] [Abstract][Full Text] [Related]
40. Calcium antagonists and sympathetic activity in congestive heart failure.
Grassi G; Bertinieri G; Turri C; Dell'Oro R; Mancia G
J Hypertens Suppl; 1998 Oct; 16(6):S9-14. PubMed ID: 9856378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
